Manufacturing Chemist serves the pharmaceutical and biopharmaceutical sectors. It offers comprehensive coverage of the industry, including drug discovery, development, manufacturing, packaging and regulatory issues. The magazine serves as a single source of information and reference for pharmaceutical researchers, scientists and decision-makers worldwide https://manufacturingchemist.com/ Copyright: (C) HPCi Media Limited, https://www.hpcimedia.com/tsandcs Thu, 01 Oct 2026 05:46:11 +0000 1800 CARBOGEN AMCIS part of the Dishman Carbogen Amcis Group, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of the first U.S. Food and Drug Administration (FDA) Pre-Approval Inspection (PAI) at its Vionnaz facility in Switzerland. The inspection concluded without the issuance of a Form 483 https://manufacturingchemist.com/carbogen-amcis-announces-successful-first-fda-pre-approval https://manufacturingchemist.com/carbogen-amcis-announces-successful-first-fda-pre-approval Wed, 30 Sep 2026 12:01:00 +0000 Lilly's retatrutide posts strong Phase III results, Novo Nordisk pays up to $2.6bn for an oral candidate and nasal and AI-designed approaches advance https://manufacturingchemist.com/glp-1-round-up-what-s-happened-weight-loss https://manufacturingchemist.com/glp-1-round-up-what-s-happened-weight-loss Wed, 30 Sep 2026 11:56:00 +0000 Booming markets for GLP-1 drugs pose special challenges to pharmaceutical manufacturers. For this purpose, Schreiner MediPharm, a leading developer and manufacturer of innovative functional labels for the healthcare industry, has developed a new multifunctional label for pens and autoinjectors combining analog and digital security features with additional benefits. Schreiner MediPharm will be presenting the label at CPHI Milan from October 6 to 8, 2026 at Booth 11F61 https://manufacturingchemist.com/schreiner-medipharm-to-present-new-multifunctional-label-for https://manufacturingchemist.com/schreiner-medipharm-to-present-new-multifunctional-label-for Wed, 30 Sep 2026 11:38:00 +0000 First new floor-standing centrifuge developed since the integration of himac into the Eppendorf Group. SpinPro 8 R combines high-speed performance with up to 6 L capacity and a selection of 35 rotors https://manufacturingchemist.com/eppendorf-introduces-the-new-spinpro-8-r-high https://manufacturingchemist.com/eppendorf-introduces-the-new-spinpro-8-r-high Wed, 30 Sep 2026 11:26:00 +0000 The expansion adds two 500-gallon reactors and enhanced early-stage containment capabilities, strengthening the Illinois site's position as Esteve's North American centre of excellence for small-molecule API development and cGMP manufacturing https://manufacturingchemist.com/esteve-further-17-5m-morton-grove-api-us-investment https://manufacturingchemist.com/esteve-further-17-5m-morton-grove-api-us-investment Wed, 30 Sep 2026 11:14:00 +0000 The agency has cited serious CGMP deficiencies at Fresenius Kabi’s Melrose Park facility, including failures involving aseptic processing, investigations, bioburden controls and visual inspection — even finding hair in some products https://manufacturingchemist.com/fda-warns-fresenius-kabi-over-sterile-manufacturing-violations https://manufacturingchemist.com/fda-warns-fresenius-kabi-over-sterile-manufacturing-violations Wed, 30 Sep 2026 09:39:00 +0000 Manufacturing, biotech and pharmaceutical, and education organisations represent the top industries for CLM adoption. Their operations involve complex supplier networks, regulatory requirements and distributed decision-making authority that manual processes cannot effectively support https://manufacturingchemist.com/what-industries-benefit-most-from-contract-lifecycle-management https://manufacturingchemist.com/what-industries-benefit-most-from-contract-lifecycle-management Tue, 29 Sep 2026 15:42:00 +0000 German CDMO Vetter is expanding its global fill-and-finish capacity with 10 new commercial filling lines, including pre-sterilised syringe and aseptic production capabilities, as part of a long-term investment programme through 2031 https://manufacturingchemist.com/vetter-expands-fill-finish-network-ten-commerical-lines https://manufacturingchemist.com/vetter-expands-fill-finish-network-ten-commerical-lines Tue, 29 Sep 2026 14:30:00 +0000 BioPharma Deals 2026 brings biopharma leaders, investors, advisors, and innovators together in Munich on 24–25 November for strategic partnerships, licensing, investment, and high-value deal-making https://manufacturingchemist.com/biopharma-deal-making-enters-a-new-phase-as https://manufacturingchemist.com/biopharma-deal-making-enters-a-new-phase-as Tue, 29 Sep 2026 14:13:00 +0000 L.B. Bohle Maschinen und Verfahren GmbH, will join its Italian agent G.B. Gnudi Bruno S.p.A. at CPHI Worldwide Milan 2026, exhibiting at Booth 9F34 in Hall 9 https://manufacturingchemist.com/l-b-bohle-puts-qbcon-1-continuous-granulation-centre https://manufacturingchemist.com/l-b-bohle-puts-qbcon-1-continuous-granulation-centre Tue, 29 Sep 2026 14:13:00 +0000 The new facility covers an area of 120,000 square feet and supports the company’s production of state-of-the-art pharmaceutical equipment, producing life-saving patient therapies. https://manufacturingchemist.com/grand-opening-ceremony-for-ima-life-north-america https://manufacturingchemist.com/grand-opening-ceremony-for-ima-life-north-america Tue, 29 Sep 2026 12:51:00 +0000 The closure of three German facilities and the Singapore plant should free up to €500m annually, redirecting capital into BioNTech's late-stage oncology pipeline as the company pivots away from pandemic-era mRNA vaccine manufacturing https://manufacturingchemist.com/biontech-closes-four-sites-failed-sale-covid-vaccine https://manufacturingchemist.com/biontech-closes-four-sites-failed-sale-covid-vaccine Tue, 29 Sep 2026 11:50:00 +0000 Pinsent Masons data shows 936 filings in the year to March 2026 — spanning oral formulations, method-of-use patents for conditions including cancer and Parkinson's and generic alternatives ahead of semaglutide's European expiry in 2031 https://manufacturingchemist.com/glp-1-patent-applications-surge-semaglutide-cliff-biosimilar https://manufacturingchemist.com/glp-1-patent-applications-surge-semaglutide-cliff-biosimilar Tue, 29 Sep 2026 10:03:00 +0000 Smaller blister runs are becoming more common in OSD manufacturing. The challenge is not simply producing fewer packs, but making sure low-volume work still meets the expectations of regulated production https://manufacturingchemist.com/when-small-blister-runs-need-production-level-thinking https://manufacturingchemist.com/when-small-blister-runs-need-production-level-thinking Tue, 29 Sep 2026 08:16:00 +0000 Explore NSF’s 2025 European Pharma & Biotech Benchmarking Study, revealing how 100 quality and regulatory leaders assess quality systems, data integrity, supply chains, AI and regulatory readiness https://manufacturingchemist.com/europe-s-pharma-quality-benchmark-the-insights-every-leader https://manufacturingchemist.com/europe-s-pharma-quality-benchmark-the-insights-every-leader Tue, 29 Sep 2026 07:00:00 +0000 The European Commission has granted marketing authorisation for Nezglyal (leriglitazone), the first pharmacological treatment approved in the EU for cerebral adrenoleukodystrophy (cALD) https://manufacturingchemist.com/neuraxpharm-minoryx-secure-eu-approval-cald-nezglyal https://manufacturingchemist.com/neuraxpharm-minoryx-secure-eu-approval-cald-nezglyal Mon, 28 Sep 2026 13:56:00 +0000 The Swedish drug delivery company has granted Novo a global licence to its PharmaShell atomic layer deposition platform for long-acting peptide medicines targeting obesity, type 2 diabetes and other cardiometabolic diseases https://manufacturingchemist.com/nanexa-signs-1-165bn-novo-deal-long-acting-injectable-technology https://manufacturingchemist.com/nanexa-signs-1-165bn-novo-deal-long-acting-injectable-technology Mon, 28 Sep 2026 13:22:00 +0000 VitsGlobal home of Lifeplan Products Ltd, a sister company of the Wasdell Group, has strengthened its manufacturing capabilities through a significant investment in two state-of-the-art Fette F20i Tablet Compression Machines and integrated tablet inspection system https://manufacturingchemist.com/vitsglobal-home-of-lifeplan-products-invests-in-next https://manufacturingchemist.com/vitsglobal-home-of-lifeplan-products-invests-in-next Mon, 28 Sep 2026 11:46:00 +0000 The company has introduced an integrated nitrite testing and regulatory support service to help pharma manufacturers assess nitrosamine risks associated with empty capsules https://manufacturingchemist.com/lonza-capsugel-launches-nitrite-testing-service-nitrosamine-risk https://manufacturingchemist.com/lonza-capsugel-launches-nitrite-testing-service-nitrosamine-risk Mon, 28 Sep 2026 09:36:00 +0000